deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01214434

Promiseb Topical Cream for Cradle Cap

A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis)

Sponsor: Promius Pharma, LLC

Conditions Cradle Cap Infantile Seborrheic Dermatitis
Interventions Bland emollient Promiseb Topical Cream
Updated 6 times since 2017 Last updated: Jan 23, 2017 Started: Mar 31, 2010 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cradle Cap and Infantile Seborrheic Dermatitis, this trial is completed. The trial is conducted by Promius Pharma, LLC and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Promius Pharma, LLC
Data source: Promius Pharma, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations